A Study of the Effect of RO4917838 on the QTcF Interval in Healthy Volunteers

NCT01613040 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Moxifloxacin
DRUG: Moxifloxacin
DRUG: RO4917838
DRUG: RO4917838
DRUG: RO4917838 placebo

Sponsor

Hoffmann-La Roche